Somaxon Pharma On Vigil

Filed in Gold Holdings, Gold Investing by on November 30, 2009 0 Comments

With the FDA decision date of December 4 looming for Somaxon Pharmaceuticals Inc. (SOMX)’s amended New Drug Application for Silenor for treatment of insomnia, the stock set a new intraday high of $4.80 for the year Monday before settling down at $3. Somaxon Pharma On Vigil

Read the original here:
Somaxon Pharma On Vigil

Tags: , , , , , , , , , , ,

About the Author ()

Leave a Reply

Your email address will not be published. Required fields are marked *